Dupilumab for atopic dermatitis linked to lower antibody levels after COVID-19 infection
Benjamin Ungar, MD, and Emma Guttman-Yassky, MD, PhD, discuss their study on how dupilumab for atopic dermatitis is linked to lower antibody levels after COVID-19 infection.
Press Release
Mount Sinai Is First in "New York" to Study a Brain-Computer Interface Designed to Record
Jan 01, 2024 View All Press ReleasesPress Release
New Insights Revealed On Tissue-Dependent Roles of JAK Signaling in Inflammation
Dec 21, 2023 View All Press Releases